Bringing the fundamentals into focus…
Back to Century Therapeutics, Inc.
How Century Therapeutics, Inc. stacks up
IPSC · against 301 other Healthcare companies of similar size
Growth
96/ 100
Near the top of its peers.
Ranked #10 of 302 · scores higher than 95% of peers
Bars: peers in each 10-point band of the growth score29 peers with a growth score of 90–100, including IPSC · Click a bar to see the companies
Why growth scores 96?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 98% of peers. 3-year revenue growth: 175.9% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 99% of peers. Revenue growth: 1556.8% vs peer median 6.1%
Metric by metric
Position: dot = IPSC, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IPSC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 316 reported | 1556.8% | 3.0% | 100% | 33% | |
| Earnings per share growthHigher is better · 141 reported | Not reported | 2.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 294 reported | 175.9% | 3.8% | 98% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around IPSC| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 2 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 2 | 592M ILS (≈$160M) | 99 | 84 | |
| 2 | 433M USD | 99 | 81 | |
| 9 | 2.6B CNY (≈$359M) | 97 | 52 | |
| 10 | 534.0B KRW (≈$385M) | 96 | 59 | |
| 10 | 377M USD | 96 | 29 | |
| 10 | 500M USD | 96 | 63 | |
| 10 | 275M USD | 96 | 46 | |
| 10 | 334M USD | 96 | 49 | |
| 10 | 172M USD | 96 | 34 | |
| 16 | 274M USD | 95 | 57 | |
| 16 | 467M USD | 95 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score